Leslie D. Funtleyder's Net Worth
$6.43 Million
Who is Leslie D. Funtleyder?
Leslie D. Funtleyder has an estimated net worth of $6.43 Million. This is based on reported shares across multiple companies, which include Applied Therapeutics, Inc., and REVIVA PHARMACEUTICALS HOLDINGS, INC..
SEC CIK
Leslie D. Funtleyder's CIK is 0001775394
Past Insider Trading and Trends
2020 was Leslie D. Funtleyder's most active year for acquiring shares with 7 total transactions. Leslie D. Funtleyder's most active month to acquire stocks was the month of May. 2020 was Leslie D. Funtleyder's most active year for disposing of shares, totalling 40 transactions. Leslie D. Funtleyder's most active month to dispose stocks was the month of May. 2020 saw Leslie D. Funtleyder paying a total of $481,265.10 for 104,144 shares, this is the most they've acquired in one year. In 2020 Leslie D. Funtleyder cashed out on 318,445 shares for a total of $5,018,468.38, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Applied Therapeutics, Inc. (APLT) Snapshot price: $5.7
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.64% | -13.53K |
$5.83 | -$78,879.90 | 277.91K |
Aug 22
| |||
Form 4
| -5.51% | -16.98K |
$4.32 | -$73,353.60 | 291.44K |
Jun 6
| |||
Form 4
| -8.52% | -28.73K |
$5.39 | -$154,838.53 | 308.42K |
Mar 14
| |||
Form 4
| +807.58% | 300K |
—
|
—
| 337.15K |
Nov 20
| |||
Form 4
| +116.63% | 20K |
—
|
—
| 37.15K |
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
| -77.77% | -60.00K |
$12.39 | -$743,113.20 | 17.15K |
Scheduled
|
Oct 1 - Oct 2
| ||
Form 4
| -47.38% | -27.08K |
$18.22 | -$254,856.40 | 17.15K |
Scheduled
|
Aug 21 - Aug 24
| ||
Form 4
| -53.84% | -20.00K |
$42.43 | -$848,554.66 | 17.15K |
Jun 23 - Jun 25
| |||
Form 4
| +50.73% | 12.5K |
$25.01 | -$245,815.74 | 37.15K |
Jun 18 - Jun 22
| |||
Form 4
| +43.73% | 7.5K |
$24.49 | -$340,882.74 | 24.65K |
Jun 15 - Jun 17
| |||
Form 4
|
—
|
0
|
$24.25 | -$664,680.44 | 17.15K |
Jun 8 - Jun 10
| |||
Form 4
|
—
|
0
|
$24.87 | -$604,890.96 | 17.15K |
Jun 2 - Jun 4
| |||
Form 4
|
—
|
0
|
$22.65 | -$834,409.14 | 17.15K |
May 28 - May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
| +50.58% | 4.64K |
—
|
—
| 13.81K |
May 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) Snapshot price: $1.36
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||